In multicenter, phase 3 #MITNEC-A1 study, 18F-sodium fluoride PET–CT was compared to 99mTc bone scintigraphy with SPECT in patients with...

In a large study reported in the New England journal of medicine, 147 out of 5547 patients (2.7%) with rectal...

In the second interim analysis of the phase III MONARCH-3 study, that was presented by Dr Matthew Goetz adding #Abemaciclib...

Secondary analysis of phase III N107C/CEC.3 trial was conducted to compare whole-brain radiotherapy [WBRT] or stereotactic radiosurgery [SRS]) regarding quality...

In phase III NEOPAN study presented by Dr. Ducreux, FOLFIRINOX improved progression-free survival (PFS) compared to gemcitabine in #locally_advanced unresectable...

#Niraparib maintenance provides a favorable OS trend compared with placebo in patients with platinum sensitive recurrent ovarian cancer regardless of...

The moderate hypofractionated radiotherapy course (3-weeks with concomitant boost) resulted in comparable safety and efficacy to the normal fractionation (4-6...

In a randomized phase III Indian study, the addition of low dose nivolumab to chemotherapy improved overall survival in patients...

In patients treated with 6 months of #oxaliplatin-based chemotherapy for stage III #colon_cancer, the prognostic impact of early discontinuation of...

The final Overall survival analysis data from the phase III PAOLA – 1 study presented by Ledermann showed that the...